BioXcel Therapeutics, Inc. - Restricted Stock Units Grant to Javier Rodriguez

On August 1, 2025, Javier Rodriguez, Chief Legal Officer, Senior Vice President, and Corporate Secretary of BioXcel Therapeutics, Inc., was granted 9,000 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the company's Common Stock. The RSUs are set to vest 100% on or within thirty days of 9 months from the grant date, provided that Rodriguez remains employed by the company or its subsidiary on that date. This transaction was reported in a Form 4 filing with the SEC on August 5, 2025. The filing indicates that Rodriguez now owns 9,000 shares of the company's Common Stock following this grant.